NPA
TMO icon

Nichols & Pratt Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Nichols & Pratt Advisers’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6M Buy
45,986
+4,268
+10% +$2.32M 1.46% 20
2025
Q4 		$24.2M Buy
41,718
+1,359
+3% +$769K 1.51% 24
2025
Q3 		$19.6M Buy
40,359
+11,157
+38% +$5.19M 1.24% 25
2025
Q2 		$11.8M Buy
29,202
+1,442
+5% +$603K 0.79% 32
2025
Q1 		$13.8M Buy
27,760
+2,852
+11% +$1.54M 0.94% 31
2024
Q4 		$13M Buy
24,908
+2,283
+10% +$1.26M 0.86% 30
2024
Q3 		$14M Buy
22,625
+2,102
+10% +$1.24M 0.9% 31
2024
Q2 		$11.3M Buy
20,523
+1,434
+8% +$822K 0.77% 32
2024
Q1 		$11.1M Buy
19,089
+1,763
+10% +$989K 0.75% 32
2023
Q4 		$9.2M Buy
17,326
+7,435
+75% +$3.6M 0.65% 33
2023
Q3 		$5.01M Buy
9,891
+9,267
+1,485% +$4.94M 0.38% 38
2023
Q2 		$326K Buy
+624
New +$337K 0.02% 90

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nichols & Pratt Advisers's TMO Position: Q1 2026 in Review

Nichols & Pratt Advisers increased its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, buying an estimated $2.32M and bringing the position to 45,986 shares worth $22.6M. The position accounts for 1.46% of the portfolio, ranked #20.

Nichols & Pratt Advisers first reported a position in TMO in Q2 2023 and has held it in 12 quarters since. The position peaked at $24.2M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Nichols & Pratt Advisers held 45,986 shares of Thermo Fisher Scientific worth $22.6M as of Q1 2026.
  • Nichols & Pratt Advisers bought 4,268 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.32M.
  • Thermo Fisher Scientific made up 1.46% of Nichols & Pratt Advisers's portfolio in Q1 2026, its #20 holding.
  • Nichols & Pratt Advisers first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 12 quarters since.
  • Nichols & Pratt Advisers's Thermo Fisher Scientific position peaked at $24.2M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2026, filed 29 Apr 2026.